Accurate, Focused Research on Law, Technology and Knowledge Discovery Since 2002

You Are Here: Home » E-Government, Government Documents » New GAO Reports: Brand-Name Prescription Drug Pricing, Corporate Crime, 2009 Tax Filing Season

New GAO Reports: Brand-Name Prescription Drug Pricing, Corporate Crime, 2009 Tax Filing Season

by on
  • Brand-Name Prescription Drug Pricing: Lack of Therapeutically Equivalent Drugs and Limited Competition May Contribute to Extraordinary Price Increases, GAO-10-201, December 22, 2009
  • Corporate Crime: DOJ Has Taken Steps to Better Track Its Use of Deferred and Non-Prosecution Agreements, but Should Evaluate Effectiveness, GAO-10-110, December 18, 2009
  • 2009 Tax Filing Season: IRS Met Many 2009 Goals, but Telephone Access Remained Low, and Taxpayer Service and Enforcement Could Be Improved, GAO-10-225, December 10, 2009
  • Maximizing DOD’s Potential to Face New Fiscal Challenges and Strengthen Interagency Partnerships, GAO-10-359CG, January 06, 2010
  • VA Health Care: Improved Oversight and Compliance Needed for Physician Credentialing and Privileging Processes, GAO-10-26, January 06, 2010
LinkedIn

Sorry, comments are closed for this post.